139 related articles for article (PubMed ID: 212990)
1. Effect of a novel adenosine deaminase inhibitor (co-vidarabine, co-V) upon the antiviral activity in vitro and in vivo of vidarabine (Vira-Atm) for DNA virus replication.
Sloan BJ; Kielty JK; Miller FA
Ann N Y Acad Sci; 1977 Mar; 284():60-80. PubMed ID: 212990
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
Falcon MG; Jones BR
J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus.
Williams BB; Lerner AM
J Infect Dis; 1975 Jun; 131(6):673-7. PubMed ID: 166117
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of adenosine deaminase by co-vidarabine and its effect on the metabolic disposition of adenine arabinoside (vidarabine).
Borondy PE; Chang T; Maschewske E; Glazko AJ
Ann N Y Acad Sci; 1977 Mar; 284():9-20. PubMed ID: 280160
[No Abstract] [Full Text] [Related]
5. Adenine arabinoside inhibition of adenovirus replication enhanced by an adenosine deaminase inhibitor.
Wigand R
J Med Virol; 1979; 4(1):59-65. PubMed ID: 119038
[TBL] [Abstract][Full Text] [Related]
6. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.
Shannon WM; Arnett G; Schabel FM; North TW; Cohen SS
Antimicrob Agents Chemother; 1980 Oct; 18(4):598-603. PubMed ID: 6255863
[TBL] [Abstract][Full Text] [Related]
7. Increased toxicity of 9-beta-D-arabinofuranosyladenine in the presence of an inhibitor of adenosine deaminase.
Plunkett W; Cohen SS
Ann N Y Acad Sci; 1977 Mar; 284():91-102. PubMed ID: 280161
[No Abstract] [Full Text] [Related]
8. Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus.
Connor JD; Sweetman L; Carey S; Stuckey MA; Buchanan R
Antimicrob Agents Chemother; 1974 Nov; 6(5):630-6. PubMed ID: 15825318
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and pharmacokinetics of the anti-varicella-zoster virus agent 6-dimethylaminopurine arabinoside.
Lambe CU; Resetar A; Spector T; Koszalka GW; Nelson DJ
Antimicrob Agents Chemother; 1992 Feb; 36(2):353-60. PubMed ID: 1318679
[TBL] [Abstract][Full Text] [Related]
10. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
11. Effect of an adenosine deaminase inhibitor on the uptake and metabolism of arabinosyl adenine (Vidarabine) by intact human erythrocytes.
Chang T; Glazko AJ
Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):127-40. PubMed ID: 935646
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor.
Schwartz PM; Shipman C; Drach JC
Antimicrob Agents Chemother; 1976 Jul; 10(1):64-74. PubMed ID: 185947
[TBL] [Abstract][Full Text] [Related]
13. Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.
North TW; Cohen SS
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4684-8. PubMed ID: 216993
[TBL] [Abstract][Full Text] [Related]
14. Carbocyclic arabinosyladenine, an adenosine deaminase resistant antiviral agent.
Vince R; Daluge S
J Med Chem; 1977 Apr; 20(4):612-3. PubMed ID: 191615
[No Abstract] [Full Text] [Related]
15. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
Plunkett W; Cohen SS
Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
[TBL] [Abstract][Full Text] [Related]
16. Combined antiviral effects of interferon, adenine, arabinoside, hypoxanthine arabinoside, and adenine arabinoside-5'-monophosphate in human fibroblast cultures.
Bryson YJ; Kronenberg LH
Antimicrob Agents Chemother; 1977 Feb; 11(2):299-306. PubMed ID: 848937
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of adenosine deaminase to increase the antitumor activity of adenine nucleoside analogues.
Plunkett W
Ann N Y Acad Sci; 1985; 451():150-9. PubMed ID: 3907452
[No Abstract] [Full Text] [Related]
18. Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Cristalli G; Franchetti P; Grifantini M; Vittori S; Lupidi G; Riva F; Bordoni T; Geroni C; Verini MA
J Med Chem; 1988 Feb; 31(2):390-3. PubMed ID: 3339608
[TBL] [Abstract][Full Text] [Related]
19. Derivatives of 3'- and 5'-deoxyadenosine: their inhibitory activity against DNA viruses.
Grytzmann B; Morr M; Wigand R
Chemotherapy; 1980; 26(5):316-22. PubMed ID: 6967001
[TBL] [Abstract][Full Text] [Related]
20. 6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virus.
Koszalka GW; Averett DR; Fyfe JA; Roberts GB; Spector T; Biron K; Krenitsky TA
Antimicrob Agents Chemother; 1991 Jul; 35(7):1437-43. PubMed ID: 1656862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
